282 related articles for article (PubMed ID: 29189317)
1. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
2. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
3. Stroke under treatment with ustekinumab for psoriatic arthritis.
Aboudiab M; Andréjak M; Husein T; Goëb V
Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
[No Abstract] [Full Text] [Related]
4. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
[TBL] [Abstract][Full Text] [Related]
5. Flare of palmoplantar psoriasis with ustekinumab.
Daniel BS; Baker C; Foley P
Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
[No Abstract] [Full Text] [Related]
6. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
Benzaquen M; Monnier J; Beaussault Y; Rouby F; Berbis P
Australas J Dermatol; 2017 Nov; 58(4):e270-e271. PubMed ID: 28660635
[No Abstract] [Full Text] [Related]
7. Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.
Mugheddu C; Atzori L; Del Piano M; Lappi A; Pau M; Murgia S; Zucca I; Rongioletti F
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833973
[TBL] [Abstract][Full Text] [Related]
8. How effective is ustekinumab in controlling psoriatic arthritis?
Bonifati C; Graceffa D
Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
[TBL] [Abstract][Full Text] [Related]
9. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
10. Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.
Haberman RH; Castillo R; Scher JU
Rheumatology (Oxford); 2021 Jul; 60(7):e225-e226. PubMed ID: 33369644
[No Abstract] [Full Text] [Related]
11. Severe dilated cardiomyopathy induced by adalimumab and ustekinumab.
Membrillo de Novales FJ; Ávila Jiménez A; Merino Meléndez L; Torres León J; López Soberón E; Fe Marqués A; Pérez Mochales JF
J Clin Rheumatol; 2015 Apr; 21(3):171-3. PubMed ID: 25807103
[No Abstract] [Full Text] [Related]
12. Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.
Gniadecki R; Bang B; Sand C
Br J Dermatol; 2016 May; 174(5):1145-6. PubMed ID: 26522308
[No Abstract] [Full Text] [Related]
13. Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.
Almirall M; Rodriguez J; Mateo L; Carrascosa JM; Notario J; Gallardo F
Clin Rheumatol; 2017 Feb; 36(2):439-443. PubMed ID: 27817126
[TBL] [Abstract][Full Text] [Related]
14. Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice.
Del Alcázar Viladomiu E; Lamas Doménech N; Salleras Redonnet M
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):606-610. PubMed ID: 30803689
[No Abstract] [Full Text] [Related]
15. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
[No Abstract] [Full Text] [Related]
16. Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
Venegas-Iribarren S; Andino-Navarrete R
Medwave; 2018 Mar; 18(2):e7174. PubMed ID: 29522505
[TBL] [Abstract][Full Text] [Related]
17. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris.
Takahashi T; Asano Y; Shibata S; Nakamura K; Nakao M; Shida R; Mitsui A; Araki M; Watanabe R; Fujita H; Tada Y; Sato S
Br J Dermatol; 2015; 172(5):1458-60. PubMed ID: 25565011
[No Abstract] [Full Text] [Related]
18. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
19. Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.
Ghosh S; Gensler LS; Yang Z; Gasink C; Chakravarty SD; Farahi K; Ramachandran P; Ott E; Strober BE
Drug Saf; 2019 Jun; 42(6):751-768. PubMed ID: 30739254
[TBL] [Abstract][Full Text] [Related]
20. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
Echeverría-García B; Nuño-González A; Dauden E; Vanaclocha F; Torrado R; Belinchón I; Pérez-Zafrilla B;
Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
[No Abstract] [Full Text] [Related]
[Next] [New Search]